Skip to main content

Ferroptomics

Aldrovandi Lab

“Using state-of-the-art ultrasensitive mass spectrometry-based technology, we aim to identify common ferroptotic signatures in pathological conditions relevant to ferroptosis."

Lipid peroxidation is the major molecular mechanism involved in oxidative damage of cellular membranes and in the toxic process that leads to a prevailing form of regulated cell death, known as ferroptosis. Our core research aim is to combine synthetic biology approaches, especially gene editing and phenotype engineering with system biology, such as (oxi-)lipidomic and metabolomic workflows, to map metabolic changes underlying the development of diseases related to ferroptosis and to identify ferroptotic-specific signatures with potential for biomarker development. 

“Using state-of-the-art ultrasensitive mass spectrometry-based technology, we aim to identify common ferroptotic signatures in pathological conditions relevant to ferroptosis."

Lipid peroxidation is the major molecular mechanism involved in oxidative damage of cellular membranes and in the toxic process that leads to a prevailing form of regulated cell death, known as ferroptosis. Our core research aim is to combine synthetic biology approaches, especially gene editing and phenotype engineering with system biology, such as (oxi-)lipidomic and metabolomic workflows, to map metabolic changes underlying the development of diseases related to ferroptosis and to identify ferroptotic-specific signatures with potential for biomarker development. 

About our Research

“Using state-of-the-art ultrasensitive mass spectrometry-based technology, we aim to identify common ferroptotic signatures in pathological conditions relevant to ferroptosis."

Lipid peroxidation is the major molecular mechanism involved in oxidative damage of cellular membranes and in the toxic process that leads to a prevailing form of regulated cell death, known as ferroptosis. Our core research aim is to combine synthetic biology approaches, especially gene editing and phenotype engineering with system biology, such as (oxi-)lipidomic and metabolomic workflows, to map metabolic changes underlying the development of diseases related to ferroptosis and to identify ferroptotic-specific signatures with potential for biomarker development. 

Scientists at Ferroptomics

Porträt Marceler Aldrovandi

Dr. Maceler Aldrovandi

Group Leader

Highlight Publications

Doll S, Freitas FP, Shah R, Aldrovandi M, Costa da Silva M, Ingold I, Grocin AG, da Silva TNX, Panzilius E, Scheel CH, Mourão A, Buday K, Sato M, Wanninger J, Vignane T, Mohana V, Rehberg M, Flatley A, Schepers A, Kurz A, White D, Sauer M, Sattler M, Tate EW, Schmitz W, Schulze A, O'Donnell V, Proneth B, Popowicz GM, Pratt DA, Friedmann Angeli JP, Conrad M.

FSP1 is a glutathione-independent ferroptosis suppressor. Nature 575, 693–698 (2019)

Contact

Porträt Marceler Aldrovandi

Dr. Maceler Aldrovandi

Group Leader

25/120